Lentigo maligna is a slow-growing, precancerous, pigmented lesion that generally occurs on the face
Gastrointestinal side effects are the most common issues with GLP-1 receptor agonists, affecting up to 4050% of patients
Since 2016, numerous cardiovascular outcome trials on GLP-1 RA have been carried out, examining the cardiovascular effect of GLP-1 RA
Cardioprotective Properties: Studies have shown that IGF-1 LR3 supports cardiovascular health by promoting cardiac development, improving heart function, and enhancing metabolic processes
Some individuals may experience digestive upset or nausea, especially if taken on an empty stomach
For patients starting GLP-1 therapy For patients adjusting doses For patients tracking side effects or progress For patients who love data (or just a little structure) Keep going